BEL 20 falls 1.87% as AI worries pressure Brussels
Published on 11/17/2026 at 22:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBrussels stocks retreat sharply
- The BEL 20 ended Tuesday at 5,986.98 points, down 1.87% from Monday's close of 6,101.33.
- Healthcare, financial and technology shares weighed on the index, with UCB, Elia and argenx among the weakest components.
- Market caution intensified ahead of Nvidia's results and amid renewed pressure on artificial-intelligence and semiconductor shares.
The BEL 20 ended Tuesday's session in Brussels at 5,986.98 points, down 1.87% from Monday's close of 6,101.33. The decline followed a broad retreat across European equities as investors reduced risk ahead of Nvidia's results and reassessed the outlook for artificial-intelligence shares.
Investing.com reported that losses in healthcare, financials and technology drove the Brussels market lower. Declining stocks outnumbered advancing shares by 72 to 22, while 13 stocks finished unchanged.
Healthcare and financials weigh
UCB was the weakest BEL 20 constituent listed by Investing.com, falling 2.81% to 286.80 euros. Elia declined 2.67% to 131.00 euros, while argenx lost 2.64% to 854.40 euros. D'Ieteren was the strongest performer, adding 0.17% to 174.90 euros. Solvay was unchanged at 24.80 euros, and Sofina slipped 0.75% to 265.60 euros.
The sector pressure came as European investors reacted to renewed weakness in technology and semiconductor shares. La Libre, citing AFP, said selling pressure in AI and semiconductor stocks had intensified ahead of Nvidia's quarterly results. The report also noted that Washington had announced tighter controls on chip exports, adding to the sector's uncertainty.
Broader European retreat
The weakness extended beyond Brussels. According to AlertaChart, the DAX fell 2.1% in Frankfurt, the FTSE 100 lost 1.9% in London and the IBEX 35 declined 1.6% in Madrid on the same day. The BEL 20's close of 5,986.98 points was its first finish below 6,000 points since the recent advance above that level.
For investors, Tuesday's move underscored the sensitivity of Belgian large caps to changes in global risk appetite. The index's composition includes healthcare, financial, technology, industrial and property companies, leaving it exposed to both sector-specific selling and broader European market moves.
